Terms: = Endocrine gland cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Diagnosis
32 results:
1. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy drives intratumoral T cells toward a proinflammatory profile in pancreatic cancer.
Heiduk M; Plesca I; Glück J; Müller L; Digomann D; Reiche C; von Renesse J; Decker R; Kahlert C; Sommer U; Aust DE; Schmitz M; Weitz J; Seifert L; Seifert AM
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36509285
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Application Value of High-Frequency Ultrasound Combined with Detection of Serum High Mobility Group Box 1, Soluble il-2 Receptor, and Thyroglobulin Antibody in Diagnosing Thyroid cancer.
Li N; Zhang J; Meng X; Yao W
J Healthc Eng; 2022; 2022():7851436. PubMed ID: 35392142
[TBL] [Abstract] [Full Text] [Related]
4. Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of il2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma.
Ahmed A; Köhler S; Klotz R; Giese N; Lasitschka F; Hackert T; Springfeld C; Zörnig I; Jäger D; Halama N
Oncoimmunology; 2021; 10(1):1962135. PubMed ID: 34408923
[TBL] [Abstract] [Full Text] [Related]
5. Relationship Between Serum Inflammatory Factor Levels and Differentiated Thyroid Carcinoma.
Zhang X; Li S; Wang J; Liu F; Zhao Y
Technol Cancer Res Treat; 2021; 20():1533033821990055. PubMed ID: 33752541
[TBL] [Abstract] [Full Text] [Related]
6. Circulating Biomarkers of Inflammation and Ovarian cancer Risk in the Nurses' Health Studies.
Peres LC; Townsend MK; Birmann BM; Conejo-Garcia JR; Kim Y; Kubzansky LD; Magpantay LI; Martinez-Maza O; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):710-718. PubMed ID: 33563649
[TBL] [Abstract] [Full Text] [Related]
7. IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas.
Crispim PCA; Jammal MP; Antão PKA; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Am J Reprod Immunol; 2020 Dec; 84(6):e13309. PubMed ID: 32698242
[TBL] [Abstract] [Full Text] [Related]
8. Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors.
Kurimoto C; Inaba H; Ariyasu H; Iwakura H; Ueda Y; Uraki S; Takeshima K; Furukawa Y; Morita S; Yamamoto Y; Yamashita S; Katsuda M; Hayata A; Akamatsu H; Jinnin M; Hara I; Yamaue H; Akamizu T
Cancer Sci; 2020 May; 111(5):1468-1477. PubMed ID: 32086984
[TBL] [Abstract] [Full Text] [Related]
9. Cytokines in peritoneal fluid of ovarian neoplasms.
de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
[TBL] [Abstract] [Full Text] [Related]
10. Stromal il2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer.
Santos TD; Jammal MP; Silveira TP; Murta EFC; Nomelini RS
Pathologica; 2019 Jun; 111(2):62-66. PubMed ID: 31388197
[TBL] [Abstract] [Full Text] [Related]
11. ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells).
Prieto-Nieto MI; Pastor D; Rodríguez-Cobos J; Pérez JP; Méndez C; Palacios E; Arranz-Alvarez M; Santos-López J; Cano-Vega M; Viñal D; Rodríguez N; Domínguez G
Clin Transl Oncol; 2019 Oct; 21(10):1432-1439. PubMed ID: 31025168
[TBL] [Abstract] [Full Text] [Related]
12. BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid cancer.
Wang F; Zhao S; Shen X; Zhu G; Liu R; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Wang Y; Xing M
J Clin Oncol; 2018 Sep; 36(27):2787-2795. PubMed ID: 30070937
[TBL] [Abstract] [Full Text] [Related]
13. Combined Immunotherapy (OK-432, il-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian cancer.
Wang YL; Peng HH; Su SY; Lin CT
Reprod Sci; 2019 Feb; 26(2):244-249. PubMed ID: 29658435
[TBL] [Abstract] [Full Text] [Related]
14. Serum interleukin measurement may help identify thyroid cancer patients with active disease.
Martins MB; Marcello MA; Batista FA; Peres KC; Meneghetti M; Ward MAL; Etchebehere ECSC; da Assumpção LVM; Ward LS
Clin Biochem; 2018 Feb; 52():1-7. PubMed ID: 28987791
[TBL] [Abstract] [Full Text] [Related]
15. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
[TBL] [Abstract] [Full Text] [Related]
16. Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian cancer.
Sanguinete MMM; Oliveira PH; Martins-Filho A; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
Immunol Invest; 2017 Oct; 46(7):677-688. PubMed ID: 28872976
[TBL] [Abstract] [Full Text] [Related]
17. Serum expression level of cytokine and chemokine correlates with progression of human ovarian cancer.
Luo JH; Zhang CY; Lu CY; Guo GH; Tian YP; Li YL
Eur J Gynaecol Oncol; 2017; 38(1):33-39. PubMed ID: 29767861
[TBL] [Abstract] [Full Text] [Related]
18. Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer.
Hao CJ; Li J; Liu P; Li XL; Hu YQ; Sun JC; Wei Y
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323126
[TBL] [Abstract] [Full Text] [Related]
19. Diffuse large B-cell lymphoma solely involving bilateral adrenal glands and stomach: report of an extremely rare case with review of the literature.
Wakabayashi M; Sekiguchi Y; Shimada A; Ichikawa K; Sugimoto K; Tomita S; Izumi H; Nakamura N; Sawada T; Ohta Y; Komatsu N; Noguchi M
Int J Clin Exp Pathol; 2014; 7(11):8190-7. PubMed ID: 25550871
[TBL] [Abstract] [Full Text] [Related]
20. CD25 identifies a subset of CD4⁺FoxP3⁻ TIL that are exhausted yet prognostically favorable in human ovarian cancer.
deLeeuw RJ; Kroeger DR; Kost SE; Chang PP; Webb JR; Nelson BH
Cancer Immunol Res; 2015 Mar; 3(3):245-53. PubMed ID: 25480168
[TBL] [Abstract] [Full Text] [Related]
[Next]
